Hs. Ahn et al., CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES IN RAT MESANGIAL CELLS, European journal of pharmacology. Molecular pharmacology section, 289(1), 1995, pp. 49-57
We characterized cyclic nucleotide phosphodiesterases isolated from ra
t mesangial cells and assessed their roles in regulating cellular cycl
ic nucleotide levels. Three peaks of phosphodiesterase activity were e
luted by a linear sodium acetate gradient from a Q Sepharose column lo
aded with the mesangial cell extract. The first peak activity was stim
ulated by Ca2+-calmodulin and inhibited by calmodulin-stimulated phosp
hodiesterase inhibitors but not by a selective cGMP specific phosphodi
esterase V inhibitor. The second, minor activity peak was stimulated b
y cyclic GMP and inhibited by EHNA [erythro-9-(2-hydroxy-3-nonyl)adeni
ne], a selective inhibitor of cyclic GMP-stimulated phosphodiesterase
II. The last peak activity was not inhibited by cyclic GMP but selecti
vely inhibited by rolipram [4-(3-cyclopentyloxy-4-methoxyphenyl)-2] or
Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone], inhibito
rs of cyclic AMP specific, cyclic GMP insensitive phosphodiesterase IV
. Based on their order of chromatographic elution, kinetic properties
and sensitivity to allosteric agents and inhibitors, the peak 1, 2 and
3 correspond to phosphodiesterase I, II and IV. The basal cyclic GMP
level was raised more effectively by selective inhibitor of phosphodie
sterase I than phosphodiesterase II. In contrast, the atrial natriuret
ic factor-induced cyclic GMP elevation was potentiated more effectivel
y by selective inhibitors of phosphodiesterase II than phosphodiestera
se I. The forskolin-induced cyclic AMP increase was greatly potentiate
d by selective phosphodiesterase IV inhibitors but not by other phosph
odiesterase inhibitors. These data suggest that phosphodiesterase I an
d II are responsible for cyclic GMP hydrolysis whereas phosphodiestera
se IV is mainly responsible for cyclic AMP hydrolysis. The relative im
portance of phosphodiesterase I and II varied with the intracellular c
yclic GMP concentration.